Novel Developments in the Prevention, Diagnosis, and Treatment of Periprosthetic Joint Infections

Journal of the American Academy of Orthopaedic Surgeons

Volumn 23, Issue , 2015, Pages S32-S43

  Parvizi, Javad ^a   Alijanipour, Pouya ^a   Barberi, Elie F ^c   Hickok, Noreen J ^b   Phillips, K Scott ^d   Shapiro, Irving M ^b   Schwarz, Edward M ^e   Stevens, Michelle H ^f   Wang, Yi ^d   Shirtliff, Mark E ^g  

^a ROTHMAN INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f MHealthcare   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTHRITIS, INFECTIOUS; BIOFILM; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; PROSTHESIS-RELATED INFECTIONS;

ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; HUMANS; PROSTHESIS-RELATED INFECTIONS;

EID: 84937395660     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/JAAOS-D-14-00455     Document Type: Article

References (119)

1. Lew DP, Waldvogel FA: Osteomyelitis. Lancet 2004;364(9431):369-379.
2. Elek SD: Experimental staphylococcal infections in the skin of man. Ann N Y Acad Sci 1956;65(3):85-90.
3. Roisman FR, Walz DT, Finkelstein AE: Superoxide radical production by human leukocytes exposed to immune complexes: Inhibitory action of gold compounds. Inflammation 1983;7(4): 355-362.
4. Santavirta S, Konttinen YT, Bergroth V, Grönblad M: Lack of immune response to methylmethacrylate in lymphocyte cultures. Acta Orthop Scand 1991;62(1):29-32.
5. Santavirta S, Konttinen YT, Saito T, et al: Immune response to polyglycolic acid implants. J Bone Joint Surg Br 1990;72(4): 597-600.
6. Wang JY, Wicklund BH, Gustilo RB, Tsukayama DT: Prosthetic metals impair murine immune response and cytokine release in vivo and in vitro. J Orthop Res 1997;15(5):688-699.
7. Sourmelis SG, Burke FD, Varian JP: A review of total elbow arthroplasty and an early assessment of the Liverpool elbow prosthesis. J Hand Surg Br 1986;11(3): 407-413.
8. Dougherty SH, Simmons RL: Endogenous factors contributing to prosthetic device infections. Infect Dis Clin North Am 1989;3(2):199-209.
9. Berbari EF, Hanssen AD, Duffy MC, et al: Risk factors for prosthetic joint infection: Case-control study. Clin Infect Dis 1998; 27(5):1247-1254.
10. François P, Vaudaux P, Lew PD: Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections. Ann Vasc Surg 1998;12(1):34-40.
11. Stoodley P, Lewandowski Z, Boyle JD, Lappin-Scott HM: Oscillation characteristics of biofilm streamers in turbulent flowing water as related to drag and pressure drop. Biotechnol Bioeng 1998;57(5):536-544.
12. Stoodley P, Debeer D, Lewandowski Z: Liquid flow in biofilm systems. Appl Environ Microbiol 1994;60(8): 2711-2716.
13. Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW: Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. J Am Dent Assoc 2009;140(10): 1259-1265.
14. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF: Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003;47(11):3407-3414.
15. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM: Microbial biofilms. Annu Rev Microbiol 1995;49:711-745.
16. Resch A, Leicht S, Saric M, et al: Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics 2006; 6(6):1867-1877.
17. Donlan RM: Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002;8(9): 881-890.
18. Parsek MR, Singh PK: Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol 2003;57:677-701.
19. National Institutes of Health Guide: Research on Microbial Biofilms. http://grants.nih.gov/grants/guide/pa-files/PA-03-047.html. Accessed January 21, 2015.
20. Wolcott RD, Rhoads DD, Bennett ME, et al: Chronic wounds and the medical biofilm paradigm. J Wound Care 2010;19 (2):45-53.
21. Brause BD: Infections associated with prosthetic joints. Clin Rheum Dis 1986;12 (2):523-536.
22. Arnold WV, Shirtliff ME, Stoodley P: Bacterial biofilms and periprosthetic infections. J Bone Joint Surg Am 2013;95 (24):2223-2229.
23. Hudson MC, Ramp WK, Nicholson NC, Williams AS, Nousiainen MT: Internalization of Staphylococcus aureus by cultured osteoblasts. Microb Pathog 1995;19(6):409-419.
24. Xu KD, McFeters GA, Stewart PS: Biofilm resistance to antimicrobial agents. Microbiology 2000;146(pt 3):547-549.
25. Meluleni GJ, Grout M, Evans DJ, Pier GB: Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J Immunol 1995;155(4): 2029-2038.
26. Ward KH, Olson ME, Lam K, Costerton JW: Mechanism of persistent infection associated with peritoneal implants. J Med Microbiol 1992;36(6): 406-413.
27. Yasuda H, Ajiki Y, Aoyama J, Yokota T: Interaction between human polymorphonuclear leucocytes and bacteria released from in-vitro bacterial biofilm models. J Med Microbiol 1994;41 (5):359-367.
28. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O: Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010;35(4):322-332.
29. Brown MR, Allison DG, Gilbert P: Resistance of bacterial biofilms to antibiotics: A growth-rate related effect? J Antimicrob Chemother 1988;22(6):777-780.
30. Harrison JJ, Turner RJ, Ceri H: Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa. Environ Microbiol 2005;7(7):981-994.
31. Lewis K: Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol 2008;322:107-131.
32. Boyd A, Chakrabarty AM: Role of alginate lyase in cell detachment of Pseudomonas aeruginosa. Appl Environ Microbiol 1994;60(7):2355-2359.
33. Butt WP: The radiology of infection. Clin Orthop Relat Res 1973;96:20-30.
34. Segall GM, Nino-Murcia M, Jacobs T, Chang K: The role of bone scan and radiography in the diagnostic evaluation of suspected pedal osteomyelitis. Clin Nucl Med 1989;14(4):255-260.
35. Wheat J: Diagnostic strategies in osteomyelitis. Am J Med 1985;78(6B): 218-224.
36. Palestro CJ, Roumanas P, Swyer AJ, Kim CK, Goldsmith SJ: Diagnosis of musculoskeletal infection using combined In-111 labeled leukocyte and Tc-99m SC marrow imaging. Clin Nucl Med 1992;17 (4):269-273.
37. Kothari NA, Pelchovitz DJ, Meyer JS: Imaging of musculoskeletal infections. Radiol Clin North Am 2001;39(4): 653-671.
38. Tehranzadeh J, Wong E, Wang F, Sadighpour M: Imaging of osteomyelitis in the mature skeleton. Radiol Clin North Am 2001;39(2):223-250.
39. Brady RA, Leid JG, Camper AK, Costerton JW, Shirtliff ME: Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect Immun 2006;74(6):3415-3426.
40. den Reijer PM, Lemmens-den Toom N, Kant S, et al: Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood. PLoS One 2013;8 (1):e53391.
41. Jacovides CL, Kreft R, Adeli B, Hozack B, Ehrlich GD, Parvizi J: Successful identification of pathogens by polymerase chain reaction (PCR)-based electron spray ionization time-of-flight mass spectrometry (ESI-TOF-MS) in culturenegative periprosthetic joint infection. J Bone Joint Surg Am 2012;94(24): 2247-2254.
42. Leid JG, Vail TL, Kofonow JM, Shirtliff ME, Brady RA: Methods and devices for the detection of biofilm. 2013. http://www.google.com/patents/US8541006. Accessed December 14, 2014.
43. Zharov VP, Mercer KE, Galitovskaya EN, Smeltzer MS: Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys J 2006;90(2): 619-627.
44. Schaffer AC, Lee JC: Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents 2008;32(suppl 1):S71-S78.
45. Weems JJ Jr, Steinberg JP, Filler S, et al: Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2006;50(8):2751-2755.
46. DeJonge M, Burchfield D, Bloom B, et al: Clinical trial of safety and efficacy of INHA21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007;151(3): 260-265, 265.e1.
47. Fowler VG, Allen KB, Moreira ED, et al: Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: A randomized trial. JAMA 2013;309(13): 1368-1378.
48. Proctor RA: Challenges for a universal Staphylococcus aureus vaccine. Clin Infect Dis 2012;54(8):1179-1186.
49. Brady RA, O'May GA, Leid JG, Prior ML, Costerton JW, Shirtliff ME: Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun 2011; 79(4):1797-1803.
50. Bagnoli F, Bertholet S, Grandi G: Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect Microbiol 2012;2:16.
51. Varrone JJ, de Mesy Bentley KL, Bello-Irizarry SN, et al: Passive immunization with anti-glucosaminidase monoclonal antibodies protects mice from implantassociated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters. J Orthop Res 2014; 32(10):1389-1396.
52. Bongartz T, Halligan CS, Osmon DR, et al: Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 2008;59(12):1713-1720.
53. Berbari EF, Osmon DR, Lahr B, et al: The Mayo prosthetic joint infection risk score: Implication for surgical site infection reporting and risk stratification. Infect Control Hosp Epidemiol 2012;33(8): 774-781.
54. Dowsey MM, Choong PF: Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res 2008;466(1):153-158.
55. Etz H, Minh DB, Henics T, et al: Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci USA 2002;99 (10):6573-6578.
56. Oshida T, Sugai M, Komatsuzawa H, Hong YM, Suginaka H, Tomasz A: A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-L-alanine amidase domain and an endo-beta-Nacetylglucosaminidase domain: Cloning, sequence analysis, and characterization. Proc Natl Acad Sci USA 1995;92(1): 285-289.
57. Sugai M, Komatsuzawa H, Akiyama T, et al: Identification of endo-beta-Nacetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus. J Bacteriol 1995; 177(6):1491-1496.
58. Yamada S, Sugai M, Komatsuzawa H, et al: An autolysin ring associated with cell separation of Staphylococcus aureus. J Bacteriol 1996;178(6): 1565-1571.
59. Heilmann C, Hartleib J, Hussain MS, Peters G: The multifunctional Staphylococcus aureus autolysin aaa mediates adherence to immobilized fibrinogen and fibronectin. Infect Immun 2005;73(8):4793-4802.
60. Eirich J, Orth R, Sieber SA: Unraveling the protein targets of vancomycin in living S. Aureus and E. faecalis cells. J Am Chem Soc 2011;133(31):12144-12153.
61. Gedbjerg N, LaRosa R, Hunter JG, et al: Anti-glucosaminidase IgG in sera as a biomarker of host immunity against Staphylococcus aureus in orthopaedic surgery patients. J Bone Joint Surg Am 2013;95(22):e171.
62. Brady RA, Leid JG, Kofonow J, Costerton JW, Shirtliff ME: Immunoglobulins to surface-associated biofilmimmunogens provide a novel means of visualization of methicillin-resistant Staphylococcus aureus biofilms. Appl Environ Microbiol 2007;73(20): 6612-6619.
63. Shirtliff M, Harro J, Leid J: Multivalent vaccine protection from staphylococcus aureus infection. 2013. http://www. google.com/patents/WO2013134225A1. Accessed December 14, 2014.
64. Antoci V Jr, King SB, Jose B, et al: Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res 2007;25(7): 858-866.
65. Ketonis C, Barr S, Adams CS, Shapiro IM, Parvizi J, Hickok NJ: Vancomycin bonded to bone grafts prevents bacterial colonization. Antimicrob Agents Chemother 2011;55(2):487-494.
66. Trampuz A, Osmon DR, Hanssen AD, Steckelberg JM, Patel R: Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res 2003; 414:69-88.
67. Trampuz A, Piper KE, Jacobson MJ, et al: Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007;357(7):654-663.
68. Bjerkan G, Witsø E, Bergh K: Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro. Acta Orthop 2009;80(2): 245-250.
69. He N, Hu J, Liu H, et al: Enhancement of vancomycin activity against biofilms by using ultrasound-targeted microbubble destruction. Antimicrob Agents Chemother 2011;55(11):5331-5337.
70. Ensing GT, Neut D, van Horn JR, van der Mei HC, Busscher HJ: The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria: An in vitro study with clinical strains. J Antimicrob Chemother 2006;58(6): 1287-1290.
71. Carmen JC, Roeder BL, Nelson JL, et al: Ultrasonically enhanced vancomycin activity against Staphylococcus epidermidis biofilms in vivo. J Biomater Appl 2004;18(4):237-245.
72. Mohan N, Chen C-S, Hsieh H-H, Wu Y-C, Chang H-C: In vivo imaging and toxicity assessments of fluorescent nanodiamonds in Caenorhabditis elegans. Nano Lett 2010;10(9):3692-3699.
73. Chow EK, Zhang X-Q, Chen M, et al: Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med 2011;3(73): 73-21.
74. Schrand AM, Huang H, Carlson C, et al: Are diamond nanoparticles cytotoxic? J Phys Chem B 2007;111(1):2-7.
75. Schrand AM, Johnson J, Dai L, et al: Safety of Nanoparticles, in Webster TJ, ed: Nanostructure Science and Technology. Springer, 2009, pp 159-187.
76. Mochalin VN, Pentecost A, Li X-M, et al: Adsorption of drugs on nanodiamond: Toward development of a drug delivery platform. Mol Pharm 2013;10(10): 3728-3735.
77. Mochalin VN, Shenderova O, Ho D, Gogotsi Y: The properties and applications of nanodiamonds. Nat Nanotechnol 2011;7(1):11-23.
78. Merkel TJ, DeSimone JM: Dodging drugresistant cancer with diamonds. Sci Transl Med 2011;3(73):73ps8.
79. Jose B, Antoci V Jr, Zeiger AR, Wickstrom E, Hickok NJ: Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus. Chem Biol 2005; 12(9):1041-1048.
80. Howlin RP, Brayford MJ, Webb JS, Cooper JJ, Aiken SS, Stoodley P: Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob Agents Chemother 2015;59(1):111-120.
81. Holt J, Hertzberg B, Weinhold P, Storm W, Schoenfisch M, Dahners L: Decreasing bacterial colonization of external fixation pins through nitric oxide release coatings. J Orthop Trauma 2011; 25(7):432-437.
82. Chakraborti M, Jackson JK, Plackett D, Gilchrist SE, Burt HM: The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibiotics. J Mater Sci Mater Med 2012; 23(7):1705-1713.
83. Garvin K, Feschuk C: Polylactidepolyglycolide antibiotic implants. Clin Orthop Relat Res 2005;437:105-110.
84. Wang Z, Wang K, Lu X, et al: BMP-2 encapsulated polysaccharide nanoparticle modified biphasic calcium phosphate scaffolds for bone tissue regeneration. J Biomed Mater Res A 2014;Jul 21:10.002/jbm.a.35282
85. Campbell AA, Song L, Li XS, et al: Development, characterization, and antimicrobial efficacy of hydroxyapatitechlorhexidine coatings produced by surface-induced mineralization. J Biomed Mater Res 2000;53(4):400-407.
86. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA: Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007;28(32):4880-4888.
87. Lin WT, Tan HL, Duan ZL, et al: Inhibited bacterial biofilm formation and improved osteogenic activity on gentamicin-loaded titania nanotubes with various diameters. Int J Nanomedicine 2014;9:1215-1230 10.2147/IJN.S57875.
88. Zhao L, Mei S, Chu PK, Zhang Y, Wu Z: The influence of hierarchical hybrid micro/nano-textured titanium surface with titania nanotubes on osteoblast functions. Biomaterials 2010;31(19): 5072-5082.
89. Prime JM: Controlling dental caries. J Am Dent Assoc 1937;24:1950-1961. http://jada.ada.org/article/S0375-8451(37) 12007-0/abstract. Accessed February 20, 2015.
90. Gosheger G, Hardes J, Ahrens H, et al: Silver-coated megaendoprostheses in a rabbit model: An analysis of the infection rate and toxicological side effects. Biomaterials 2004;25(24): 5547-5556.
91. Collinge CA, Goll G, Seligson D, Easley KJ: Pin tract infections: Silver vs uncoated pins. Orthopedics 1994;17(5): 445-448.
92. Shimazaki T, Miyamoto H, Ando Y, et al: In vivo antibacterial and silver-releasing properties of novel thermal sprayed silvercontaining hydroxyapatite coating. J Biomed Mater Res B Appl Biomater 2010; 92(2):386-389.
93. Hobman JL, Crossman L: Bacterial antimicrobial metal ion resistance. J Med Microbiol 2014;Nov 23 [Epub ahead of print].
94. Pountos I, Georgouli T, Henshaw K, Howard B, Giannoudis PV: Mesenchymal Stem Cell physiology can be affected by antibiotics: An in vitro study. Cell Mol Biol (Noisy-le-grand) 2014;60(4):1-7.
95. Edupuganti OP, Antoci V Jr, King SB, et al: Covalent bonding of vancomycin to Ti6Al4V alloy pins provides long-term inhibition of Staphylococcus aureus colonization. Bioorg Med Chem Lett 2007;17(10):2692-2696.
96. Danahy MP, AvaltroniMJ, Midwood KS, Schwarzbauer JE, Schwartz J: Selfassembled monolayers of alpha, omegadiphosphonic acids on Ti enable complete or spatially controlled surface derivatization. Langmuir 2004;20(13): 5333-5337.
97. Heijink A, Schwartz J, Zobitz ME, Nicole Crowder K, Lutz GE, Sibonga JD: Selfassembled monolayer films of phosphonates for bonding RGD to titanium. Clin Orthop Relat Res 2008; 466(4):977-984.
98. Puleo DA, Kissling RA, Sheu MS: A technique to immobilize bioactive proteins, including bone morphogenetic protein-4 (BMP-4), on titanium alloy. Biomaterials 2002;23(9):2079-2087.
99. Loll PJ, Axelsen PH: The structural biology of molecular recognition by vancomycin. Annu Rev Biophys Biomol Struct 2000;29:265-289.
100. Stewart S, Barr S, Engiles J, et al: Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: A proof-of-concept study. J Bone Joint Surg Am 2012;94(15): 1406-1415.
101. Colling K, Statz C, Glover J, Banton K, Beilman G: Pre-Operative Antiseptic Shower and Bath Policy Decreases the Rate of S. Aureus and Methicillin-Resistant S. Aureus Surgical Site Infections in Patients Undergoing Joint Arthroplasty. Surg Infect (Larchmt) 2014;Nov18 [Epub ahead of print].
102. Yuste JR, Quesada M, Diáz-Rada P, Del Pozo JL: Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: Safety and efficacy of high-dose and prolonged therapy. Int J Infect Dis 2014;27:65-66.
103. de Sanctis J, Teixeira L, van Duin D, et al: Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: A unique challenge in the era of untreatable infections. Int J Infect Dis 2014;25:73-78.
104. Boucher HW, Talbot GH, Benjamin DK Jr, et al; Infectious Diseases Society of America: 10 x '20 Progress: Development of new drugs active against gram-negative bacilli. An update from the Infectious Diseases Society of America. Clin Infect Dis 2013;56(12):1685-1694.
105. Byren I, Rege S, Campanaro E, et al: Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing twostage revision arthroplasty. Antimicrob Agents Chemother 2012;56(11): 5626-5632.
106. Rao N, Hamilton CW: Efficacy and safety of linezolid for Gram-positive orthopedic infections: A prospective case series. Diagn Microbiol Infect Dis 2007;59(2): 173-179.
107. Lin JC, Aung G, Thomas A, Jahng M, Johns S, Fierer J: The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: A retrospective case series of 10 patients. J Infect Chemother 2013;19 (1):42-49.
108. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J: Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012;27(8 suppl): 61-65.
109. Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW: Biofilm formation in Staphylococcus implant infections: A review ofmolecularmechanisms and implications for biofilm-resistant materials. Biomaterials 2012;33(26): 5967-5982.
110. Bryers JD: Medical biofilms. Biotechnol Bioeng 2008;100(1):1-18.
111. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: A common cause of persistent infections. Science 1999;284 (5418):1318-1322.
112. Joo H-S, Otto M: Molecular basis of in vivo biofilm formation by bacterial pathogens. Chem Biol 2012;19(12):1503-1513.
113. Darouiche RO: Device-associated infections: A macroproblem that starts with microadherence. Clin Infect Dis 2001;33(9):1567-1572.
114. Busscher HJ, van der Mei HC, Subbiahdoss G, et al: Biomaterialassociated infection: Locating the finish line in the race for the surface. Sci Transl Med 2012;4(153):153rv10.
115. Vertes A, Hitchins V, Phillips KS: Analytical challenges of microbial biofilms on medical devices. Anal Chem 2012;84(9):3858-3866.
116. Bjarnsholt T, Ciofu O, Molin S, Givskov M, Høiby N: Applying insights from biofilm biology to drug development: Can a new approach be developed? Nat Rev Drug Discov 2013; 12(10):791-808.
117. Lebeaux D, Chauhan A, Rendueles O, Beloin C: From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. Pathogens 2013;2(2): 288-356.
118. Prevent Health Care-Associated Infections (HAIs) j Health.gov (ODPHP). http://www.health.gov/hai/prevent-hai.asp. Accessed December 6, 2014.
119. Phillips KS, Patwardhan D, Jayan G: Biofilms, medical devices, and antibiofilm technology: Key messages from a recent public workshop. Am J Infect Control 2015;43 (1):2-3.